首页> 外文期刊>Ophthalmology and therapy. >“Doctor, I have a Sulfa Allergy”: Clarifying the Myths of Cross-Reactivity
【24h】

“Doctor, I have a Sulfa Allergy”: Clarifying the Myths of Cross-Reactivity

机译:“医生,我对磺胺过敏”:澄清交叉反应的神话

获取原文
           

摘要

Our purpose is to present an evidence-based approach, directed primarily towards eye-care specialists, clarifying whether certain drugs should or should not be used in patients with sulfonamide allergy. We conducted a literature search using PubMed to identify the risk of ophthalmic-specific drugs in patients with a self-reported sulfonamide allergy. MeSH key words included “sulfonamide” and “hypersensitivity”. Articles specifically geared towards ophthalmic diseases were sought. The evidence illustrates that individuals with sulfonamide allergy are intrinsically predisposed to higher rates of allergic reaction that is not specific towards sulfonamide non-antimicrobials or sulfur-based medications. We provide a simplified algorithm using the 2017 Clinical Guide to Ophthalmic Drugs to help busy eye care clinicians determine whether a certain common ophthalmic medication is safe or unsafe to prescribe in a patient with a “sulfa allergy”.
机译:我们的目的是提出一种主要针对眼保健专家的循证方法,以明确某些药物是否应用于磺胺过敏患者。我们使用PubMed进行了文献检索,以鉴定自我报告的磺胺过敏患者的眼科专用药物风险。 MeSH关键字包括“磺酰胺”和“超敏性”。寻找专门针对眼科疾病的文章。证据表明,具有磺酰胺过敏症的人天生就有较高的过敏反应发生率,这对磺酰胺类非抗菌药物或基于硫的药物并不具有特异性。我们使用《 2017年眼科药物临床指南》提供了一种简化算法,以帮助繁忙的眼科护理临床医生确定某些常见的眼科用药对于患有“磺胺过敏”的患者是安全的还是不安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号